| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-122 | Doxorubicin (Adriamycin) | hepatocarcinoma | Sensitive | Low | 19584283 | |
| miR-122 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 21750653 | |
| miR-122 | Doxorubicin (Adriamycin) | hepatocellular carcinoma | Sensitive | Low | 21802841 | |
| miR-122 | Doxorubicin (Adriamycin) | cutaneous T-cell lymphoma | Resistant | Low | 22235305 | |
| miR-1224 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-1229 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-1224 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 25407491 | |
| miR-1226 | Doxorubicin (Adriamycin) | liver cancer | Sensitive | High | 25698578 | |
| miR-1226* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-1228* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 |